Our nanoplatform-peptide amphiphile micelles (PAMs) revolutionizes highly safe drug and gene delivery by targeting the disease sites and minimizing off-target side effect. Our nanoplatform will enhance therapeutic outcomes of existing medications, thereby extending patient lifespans. Moreover, by enhancing treatment effectiveness and reducing complications, our innovation stands to substantially decrease healthcare costs for society, marking a substantial societal impact.
Is this your company?
Something looks off?